Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$89.9M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$71.9M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$69M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$66M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$33M |
| 2 |
Altria Group
MO
|
+$32.4M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$26.5M |
| 4 |
CVS Health
CVS
|
+$24.7M |
| 5 |
Medtronic
MDT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.23% |
| 2 | Technology | 14.6% |
| 3 | Healthcare | 11.36% |
| 4 | Industrials | 11.26% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SCMP
1201
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $260K | 0.01% |
24,808
-6,360
| -20% | -$64.8K |
2016 Q4
2 quarters
|
|
|
FBC
1202
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $260K | 0.01% |
+8,437
| New | +$249K |
2017 Q2
0 quarters
|
|
1203
Oxford Industries
OXM
$440M
| $258K | 0.01% |
4,121
-5,964
| -59% | -$344K |
2017 Q1
1 quarter
|
|
1204
DELISTED
Seadrill Limited Common Stock
SDRL
| $258K | 0.01% |
2,667
+2,565
| +2,515% | +$403K |
2016 Q4
2 quarters
|
|
1205
Herbalife
HLF
$1.6B
| $257K | 0.01% |
+7,200
| New | +$243K |
2017 Q2
0 quarters
|
|
|
CTRL
1206
DELISTED
Control4 Corporation
CTRL
| $257K | 0.01% |
13,100
-16,132
| -55% | -$290K |
2016 Q4
2 quarters
|
|
1207
Hilltop Holdings
HTH
$2.07B
| $254K | 0.01% |
9,707
-993
| -9% | -$26.3K |
2017 Q1
1 quarter
|
|
1208
NovaGold Resources
NG
$2.81B
| $254K | 0.01% |
+55,801
| New | +$240K |
2017 Q2
0 quarters
|
|
|
AFSI
1209
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $254K | 0.01% |
16,783
-246
| -1% | -$3.63K |
2016 Q4
2 quarters
|
|
1210
Halozyme
HALO
$11.8B
| $253K | 0.01% |
+19,763
| New | +$264K |
2017 Q2
0 quarters
|
|
|
CLVS
1211
DELISTED
Clovis Oncology, Inc.
CLVS
| $253K | 0.01% |
+2,700
| New | +$165K |
2017 Q2
0 quarters
|
|
1212
OneSpan
OSPN
$797M
| $252K | 0.01% |
17,554
-8,436
| -32% | -$116K |
2017 Q1
1 quarter
|
|
1213
DELISTED
Sage Therapeutics
SAGE
| $252K | 0.01% |
3,163
-3,583
| -53% | -$259K |
2016 Q4
2 quarters
|
|
1214
DELISTED
Cadence Bank
CADE
| $251K | ﹤0.01% |
+8,237
| New | +$247K |
2017 Q2
0 quarters
|
|
1215
Celanese
CE
$5.1B
| $251K | ﹤0.01% |
2,649
-16,459
| -86% | -$1.47M |
2016 Q4
2 quarters
|
|
1216
Trustmark
TRMK
$2.58B
| $251K | ﹤0.01% |
+7,794
| New | +$250K |
2017 Q2
0 quarters
|
|
1217
NexPoint Residential Trust
NXRT
$415M
| $249K | ﹤0.01% |
+10,009
| New | +$250K |
2017 Q2
0 quarters
|
|
1218
Becton Dickinson
BDX
$57.7B
| $248K | ﹤0.01% |
1,301
-8,556
| -87% | -$1.56M |
2016 Q2
4 quarters
|
|
1219
CytomX Therapeutics
CTMX
$477M
| $248K | ﹤0.01% |
+16,000
| New | +$241K |
2017 Q2
0 quarters
|
|
1220
Inogen
INGN
$160M
| $248K | ﹤0.01% |
2,600
-12,828
| -83% | -$1.1M |
2017 Q1
1 quarter
|
|
1221
Ingevity
NGVT
$2.03B
| $248K | ﹤0.01% |
+4,316
| New | +$254K |
2017 Q2
0 quarters
|
|
|
FTD
1222
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $248K | ﹤0.01% |
+12,409
| New | +$239K |
2017 Q2
0 quarters
|
|
1223
8x8 Inc
EGHT
$311M
| $247K | ﹤0.01% |
+16,961
| New | +$241K |
2017 Q2
0 quarters
|
|
1224
St. Joe Company
JOE
$3.96B
| $247K | ﹤0.01% |
+13,170
| New | +$233K |
2017 Q2
0 quarters
|
|
1225
Starbucks
SBUX
$120B
| $247K | ﹤0.01% |
+4,241
| New | +$256K |
2017 Q2
0 quarters
|
|
Similar funds
Squarepoint's Q2 2017 Portfolio in Review
As of Q2 2017, Squarepoint held 2,064 positions worth $5.08B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Squarepoint deployed $1.39B of net new capital in Q2 2017, opening 586 new positions and adding to 519 existing holdings. Its largest new stake was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $33M trimmed.
- Squarepoint's largest Q2 2017 buy was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
- Squarepoint added most to VanEck Gold Miners ETF in Q2 2017, an estimated $71.9M increase.
- Squarepoint's biggest Q2 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $33M.
- Squarepoint fully exited iShares MSCI EAFE ETF in Q2 2017, selling an estimated $26.5M.
- Squarepoint's ten largest holdings make up 16% of its $5.08B portfolio in Q2 2017.
- Squarepoint opened 586 new positions and closed 568 in Q2 2017.
- Squarepoint's portfolio value rose 40% quarter-over-quarter to $5.08B.
Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.